Neelapu S - Search Results

1

CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphoma.

Takahashi K, Sivina M, Hoellenriegel J, Oki Y, Hagemeister FB, Fayad L, Romaguera JE, Fowler N, Fanale MA, Kwak LW, Samaniego F, Neelapu S, Xiao L, Huang X, Kantarjian H, Keating MJ, Wierda W, Fu K, Chan WC, Vose JM, O'Brien S, Davis RE, Burger JA. Takahashi K, et al. Among authors: neelapu s. Br J Haematol. 2015 Dec;171(5):726-35. doi: 10.1111/bjh.13659. Epub 2015 Sep 11. Br J Haematol. 2015. PMID: 26358140 Free PMC article.

2

Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.

Ruffini PA, Neelapu SS, Kwak LW, Biragyn A. Ruffini PA, et al. Among authors: neelapu ss. Haematologica. 2002 Sep;87(9):989-1001. Haematologica. 2002. PMID: 12217812 Review.

3

Adoptive immunotherapy with antigen-specific T cells in myeloma: a model of tumor-specific donor lymphocyte infusion.

Kwak LW, Neelapu SS, Bishop MR. Kwak LW, et al. Among authors: neelapu ss. Semin Oncol. 2004 Feb;31(1):37-46. doi: 10.1053/j.seminoncol.2003.11.001. Semin Oncol. 2004. PMID: 14970936 Review.

4

A modified human ELISPOT assay to detect specific responses to primary tumor cell targets.

Malyguine A, Strobl SL, Shafer-Weaver KA, Ulderich T, Troke A, Baseler M, Kwak LW, Neelapu SS. Malyguine A, et al. Among authors: neelapu ss. J Transl Med. 2004 Mar 29;2(1):9. doi: 10.1186/1479-5876-2-9. J Transl Med. 2004. PMID: 15050026 Free PMC article.

5

Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma.

Neelapu SS, Kwak LW, Kobrin CB, Reynolds CW, Janik JE, Dunleavy K, White T, Harvey L, Pennington R, Stetler-Stevenson M, Jaffe ES, Steinberg SM, Gress R, Hakim F, Wilson WH. Neelapu SS, et al. Nat Med. 2005 Sep;11(9):986-91. doi: 10.1038/nm1290. Epub 2005 Aug 21. Nat Med. 2005. PMID: 16116429 Clinical Trial.

6

Cloning of B cell lymphoma-associated antigens using modified phage-displayed expression cDNA library and immunized patient sera.

Cha SC, Kwak LW, Ruffini PA, Qin H, Neelapu S, Biragyn A. Cha SC, et al. Among authors: neelapu s. J Immunol Methods. 2006 May 30;312(1-2):79-93. doi: 10.1016/j.jim.2006.02.013. Epub 2006 Mar 31. J Immunol Methods. 2006. PMID: 16631194 Free PMC article.

7

Prophylactic anti-tumor effects in a B cell lymphoma model with DNA vaccines delivered on polyethylenimine (PEI) functionalized PLGA microparticles.

Pai Kasturi S, Qin H, Thomson KS, El-Bereir S, Cha SC, Neelapu S, Kwak LW, Roy K. Pai Kasturi S, et al. Among authors: neelapu s. J Control Release. 2006 Jul 20;113(3):261-70. doi: 10.1016/j.jconrel.2006.04.006. Epub 2006 May 3. J Control Release. 2006. PMID: 16793161

8

Therapeutic lymphoma vaccines: importance of T-cell immunity.

Neelapu SS, Lee ST, Qin H, Cha SC, Woo AF, Kwak LW. Neelapu SS, et al. Expert Rev Vaccines. 2006 Jun;5(3):381-94. doi: 10.1586/14760584.5.3.381. Expert Rev Vaccines. 2006. PMID: 16827622 Free article. Review.

9

Therapeutic vaccine for lymphoma.

Lee ST, Neelapu SS, Kwak LW. Lee ST, et al. Among authors: neelapu ss. Yonsei Med J. 2007 Feb 28;48(1):1-10. doi: 10.3349/ymj.2007.48.1.1. Yonsei Med J. 2007. PMID: 17326239 Free PMC article. Review.

10

A novel proteoliposomal vaccine induces antitumor immunity against follicular lymphoma.

Neelapu SS, Gause BL, Harvey L, Lee ST, Frye AR, Horton J, Robb RJ, Popescu MC, Kwak LW. Neelapu SS, et al. Blood. 2007 Jun 15;109(12):5160-3. doi: 10.1182/blood-2006-12-063594. Epub 2007 Mar 5. Blood. 2007. PMID: 17339422 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

309 results

Search Page

Filters